Interest of EMDR Schizophrenic Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

6 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-10

Study Completion Date

2022-04-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the interest of the use of EMDR (Eye Movement Desensitization and Reprocessing) psychotherapy in the management of psychotic disorders, in particular schizophrenic disorders.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pain and Schizophrenia

NCT01244542

Pain Schizophrenia

TERMINATED NA

Externalization and Stimulation

NCT05936307

Healthy Participants

UNKNOWN NA

The Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia

NCT05957484

Schizophrenia Anosognosia

TERMINATED NA

Characterization of Emotional Processing of Information in Bipolar Disorder and Schizophrenic Patients

NCT02841345

Schizophrenia Bipolar Disorder

UNKNOWN NA

Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study

NCT00350935

Schizophrenia

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Since 2015 more and more studies conducted by researchers, especially Dutch and English, are interested in the use of EMDR (Eye Movement Desensitization and Reprocessing) for other pathologies such as bipolar disorder, unipolar depression, anxiety disorders, psychotic disorders, substance use disorders and chronic pain.

These studies show that EMDR appears to be a technique that is both effective, capable of significantly improving symptoms, and without risk for patients, while respecting the protocol and the clinical stabilization provided during the procedure.

To date, the use of EMDR for the management of psychotic patients has not been the subject of any prospective study in France and the authors' conclusions converge on the fact that it is essential to carry out more research on the subject.

For this, the investigators wish to evaluate the effect of EMDR on the management of patients with schizophrenic disorders, on the basis that this psychotherapy would improve their quality of life (improvement of all the specific scores used in psychiatry). : PANSS, DES, HAD and WEMWBS scales).

Finally, the investigators believe that it is relevant to assess the benefit of EMDR six months after hospitalization of patients, in order to measure the maintenance of this efficacy in the medium term

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenic Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Patients in the control group will have simple consultations on D15, D30, D45, D60 and D75

Control group

Intervention Type OTHER

Patients in the control group will have simple consultations on D15, D30, D45, D60 and D75

EMDR group

Patients in the EMDR group will have EMDR session on D15, D30, D45, D60 and D75

EMDR group

Intervention Type OTHER

Patients in the EMDR group will have EMDR session on D15, D30, D45, D60 and D75

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control group

Patients in the control group will have simple consultations on D15, D30, D45, D60 and D75

Intervention Type OTHER

EMDR group

Patients in the EMDR group will have EMDR session on D15, D30, D45, D60 and D75

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 18 years and over,
* Hospitalized for decompensated psychotic disorder, Positive diagnosis of schizophrenia or schizoaffective disorder (according to the DSM-V psychiatry manual),
* With positive or negative symptoms according to the Positive and Negative Syndrome Scale (PANSS),
* Stabilized clinical condition (considered compatible with hospital discharge),
* With ambulatory follow-up planned after hospitalization

Exclusion Criteria

* \< 18 years,
* Patients who do not meet the diagnostic criteria (according to the DSM-V psychiatry manual) for schizophrenic or schizoaffective disorder),
* Non-French speaking or illiterate patients,
* Cognitive disorders making it impossible the understanding and the none- opposition to the study,
* Non-stabilized clinical condition (incompatible with hospital discharge),

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No